Table 7.
Results about prevalence and incidence of LBP
| Author, year | Study design | Incidence | Prevalence | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Lifetime | 1 year | Point | Other | Lifetime | 1 year | Point | Other | ||
| Bach DK, 1985 [72] | Prospective Cohort | 22% | |||||||
| Besomi M, 2019 [66] | Cross Sectional Survey | 13.5% | 0.7% | ||||||
| Buist I, 2008 [73] | Prospective Cohort | 4.8% (protocol event: 8 weeks) | |||||||
| Chang WL, 2012 [67] | Cross Sectional Survey | 3.2% | |||||||
| Clement DB, 1981 [69] | Retrospective Survey | 3.7% (2 years) | |||||||
| Dallinga J, 2019 [80] | Prospective Cohort | 1.9% (protocol event: 12 weeks) | |||||||
| Ellapen TJ, 2013 [70] | Retrospective Descriptive | 14% | |||||||
| Kluitenberg B, 2015 [76] | Prospective Cohort | 0.3% (protocol event: 6 weeks) | |||||||
| Lysholm J, 1987 [74] | Prospective Cohort | 5% | |||||||
| Marti B, 1988 [68] | Cross Sectional Survey | 0.7% | |||||||
| Malliaropoulos N, 2015 [64] | Cross Sectional | 20.2% | |||||||
| Messier SP, 2018 [79] | Prospective Cohort | 6% (2 years) | |||||||
| Rasmussen CH, 2013 [71] | Retrospective Cohort | 0.5% | |||||||
| Tauton JE, 2003 [75] | Prospective Cohort | 1.6% (protocol event: 13 weeks) | |||||||
| Teixeira RN, 2016 [65] | Cross Sectional | 14% | |||||||
| Van der Worp MP, 2016 [77] | Prospective Cohort | 2.7% (12 weeks) | |||||||
| Von Rosen P, 2017 [78] | Prospective Cohort | 2.8% | |||||||
| Walter SD, 1989 [81] | Prospective Cohort | 1.8% | 4.3% | ||||||
| Woolf SK, 2002 [63] | Cross Sectional Survey | 13.6% | |||||||